Prosecution Insights
Last updated: April 19, 2026

Expression Therapeutics LLC

3 pending office actions

Portfolio Summary

3
Total Pending OAs
0
Final Rejections
3
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18542586 Factor VIII Molecules and Their Use MATALKAH, FATIMAH KHALAF 1638 Non-Final OA Dec 15, 2023
18095484 Engineered T Cells MELCHIOR, JAMES RYLAND 1644 Non-Final OA Jan 10, 2023
17927078 Lentiviral System MATALKAH, FATIMAH KHALAF 1638 Non-Final OA Nov 22, 2022

Managing Expression Therapeutics LLC's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month